All Stories

  1. Automated enzymatic hydrolysis of urine samples for improved systematic toxicological analysis of drug‐facilitated sexual assault cases
  2. CCH attack frequency reduction after psilocybin correlates with hypothalamic functional connectivity
  3. Exploring Enzymatic Hydrolysis of Urine Samples for Investigation of Drugs Associated with Drug-Facilitated Sexual Assault
  4. Uncovering forensic evidence of drug-facilitated sexual assault: Toxicological findings from Eastern Denmark from 2015–2022
  5. Detection of scopolamine in urine and hair in a drug-facilitated sexual assault
  6. Driving under the Influence of Amphetamine: Analytical Evaluation of Illegal or Prescription Drug Intake Using Chiral UHPLC–MS-MS
  7. Improving analysis of urine samples from drug-facilitated sexual assault cases
  8. Psilocybin-induced reduction in chronic cluster headache attack frequency correlates with changes in hypothalamic functional connectivity
  9. Concentrations of citalopram and escitalopram in postmortem hair segments
  10. A Systematic Review of Metabolite-to-Drug Ratios of Pharmaceuticals in Hair for Forensic Investigations
  11. Psilocybin-induced changes in brain network integrity and segregation correlate with plasma psilocin level and psychedelic experience
  12. Hair cortisol concentrations in decedents with severe mental illness – An autopsy-based cohort study
  13. Psilocybin-induced changes in brain network integrity and segregation correlate with plasma psilocin level and psychedelic experience
  14. Effects of a single dose of psilocybin on behaviour, brain 5-HT2A receptor occupancy and gene expression in the pig
  15. Concentrations of aripiprazole and dehydroaripiprazole in hair segments from deceased individuals with mental disorders
  16. Temporal patterns of tramadol in hair after a single dose
  17. Segmental hair analysis of olanzapine and N-desmethyl-olanzapine in postmortem hair from mentally ill patients by LC–MS/MS
  18. Internal quality control samples for hair testing
  19. In vitro and in vivo metabolism and detection of 3‐HO‐PCP, a synthetic phencyclidine, in human samples and pooled human hepatocytes using high resolution mass spectrometry
  20. Postmortem Brain–Blood Ratios of Codeine, Fentanyl, Oxycodone and Tramadol
  21. Ketamine analogues: Comparative toxicokinetic in vitro–in vivo extrapolation and quantification of 2-fluorodeschloroketamine in forensic blood and hair samples
  22. Distribution of zopiclone and main metabolites in hair following a single dose
  23. Hair testing for cortisol by UPLC–MS/MS in a family: External cross-contamination from use of cortisol cream
  24. Brain-blood ratio of morphine in heroin and morphine autopsy cases
  25. Amitriptyline accumulation in tissues after coated activated charcoal hemoperfusion—a randomized controlled animal poisoning model
  26. Identification of phenobarbital and other barbiturates in forensic drug screening using positive electrospray ionization liquid chromatography−high resolution mass spectrometry
  27. Efficacy and safety of dantrolene in toxic hyperthermia: a systematic review
  28. Psychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levels
  29. Postmortem Brain–Blood Ratios of Amphetamine, Cocaine, Ephedrine, MDMA and Methylphenidate
  30. Psilocybin occupancy of brain serotonin 2A receptors correlates with psilocin levels and subjective experience: a [11C]Cimbi-36 PET study in humans
  31. Retrospective analysis for valproate screening targets with liquid chromatography–high resolution mass spectrometry with positive electrospray ionization: An omics‐based approach
  32. Fatal intoxications among non-drug addicts in Eastern Denmark over a 5-year period (2008–2012)
  33. Segmental Hair Analysis-Interpretation of the Time of Drug Intake in Two Patients Undergoing Drug Treatment
  34. Postmortem analysis of three methoxyacetylfentanyl-related deaths in Denmark and in vitro metabolite profiling in pooled human hepatocytes
  35. Segmental Analysis of Chlorprothixene and Desmethylchlorprothixene in Postmortem Hair
  36. Reference Brain and Blood Concentrations of Olanzapine in Postmortem Cases
  37. Definition and treatment of benzodiazepine-resistant ethanol withdrawal syndrome
  38. Hair analysis in toxicological investigation of drug-facilitated crimes in Denmark over a 8-year period
  39. Post-mortem quetiapine concentrations in hair segments of psychiatric patients — Correlation between hair concentration, dose and concentration in blood
  40. Validation of a fully automated solid‐phase extraction and ultra‐high‐performance liquid chromatography–tandem mass spectrometry method for quantification of 30 pharmaceuticals and metabolites in post‐mortem blood and brain samples
  41. Reference Brain/Blood Concentrations of Citalopram, Duloxetine, Mirtazapine and Sertraline
  42. Application of a screening method for fentanyl and its analogues using UHPLC‐QTOF‐MS with data‐independent acquisition (DIA) in MSE mode and retrospective analysis of authentic forensic blood samples
  43. Advantages of analyzing postmortem brain samples in routine forensic drug screening—Case series of three non-natural deaths tested positive for lysergic acid diethylamide (LSD)
  44. Determination of GHB and GHB-β-O-glucuronide in hair of three narcoleptic patients—Comparison between single and chronic GHB exposure
  45. Enantioselective analysis of citalopram and demethylcitalopram in human whole blood by chiral LC-MS/MS and application in forensic cases
  46. Simultaneous determination of ethanol's four types of non-oxidative metabolites in human whole blood by liquid chromatography tandem mass spectrometry
  47. Postmortem concentrations of gamma-hydroxybutyrate (GHB) in peripheral blood and brain tissue — Differentiating between postmortem formation and antemortem intake
  48. In vitro studies on flubromazolam metabolism and detection of its metabolites in authentic forensic samples
  49. Detection of the antipsychotic drug quetiapine in the blood, urine and hair samples of the victim of a drug-facilitated sexual assault
  50. Gamma-Hydroxybutyrate (GHB) Content in Hair Samples Correlates Negatively with Age in Succinic Semialdehyde Dehydrogenase Deficiency
  51. The significance of sampling time in therapeutic drug monitoring of clozapine
  52. Deposition of diazepam and its metabolites in hair following a single dose of diazepam
  53. Postmortem Brain and Blood Reference Concentrations of Alprazolam, Bromazepam, Chlordiazepoxide, Diazepam, and their Metabolites and a Review of the Literature
  54. Sensitive, automatic method for the determination of diazepam and its five metabolites in human oral fluid by online solid-phase extraction and liquid chromatography with tandem mass spectrometry
  55. Drug facilitated sexual assault with lethal outcome: GHB intoxication in a six-year-old girl
  56. Targeted analysis of 116 drugs in hair by UHPLC-MS/MS and its application to forensic cases
  57. Development of a UPLC–MS/MS method for determining γ-hydroxybutyric acid (GHB) and GHB glucuronide concentrations in hair and application to forensic cases
  58. Postmortem Quetiapine Reference Concentrations in Brain and Blood
  59. Evaluation of poly-drug use in methadone-related fatalities using segmental hair analysis
  60. Stability of  -Hydroxybutyrate in Blood Samples from Impaired Drivers after Storage at 4 C and Comparison of GC-FID-GBL and LC-MS-MS Methods of Analysis
  61. Postmortem Femoral Blood Reference Concentrations of Aripiprazole, Chlorprothixene, and Quetiapine
  62. O6: Intoxications detected by hair analysis of bleached and non-bleached hair
  63. Pre-analytical and analytical variation of drug determination in segmented hair using ultra-performance liquid chromatography–tandem mass spectrometry
  64. Validation of a method for the targeted analysis of 96 drugs in hair by UPLC–MS/MS
  65. Screening of Danish traffic cases for synthetic cannabinoids in whole blood by LC-MS/MS
  66. Postmortem Femoral Blood Concentrations of Risperidone
  67. Evaluation of metabolite/drug ratios in blood and urine as a tool for confirmation of a reduced tolerance in methadone-related deaths in Denmark
  68. Screening for illicit and medicinal drugs in whole blood using fully automated SPE and ultra‐high‐performance liquid chromatography with TOF‐MS with data‐independent acquisition
  69. Severe Methylphenidate Intoxication-Charcoal Hemoperfusion as an Aid in Treating the Patient
  70. Simultaneous Determination of 25 Common Pharmaceuticals in Whole Blood Using Ultra-Performance Liquid Chromatography-Tandem Mass Spectrometry
  71. Fatal intoxications among non-drug addicts in Eastern Denmark over a five-year period (2003–2007)
  72. In vitro metabolism studies on mephedrone and analysis of forensic cases
  73. Isomers of fluoroamphetamines detected in forensic cases in Denmark
  74. Distribution Patterns, Dermatomal Anesthesia, and Ropivacaine Serum Concentrations After Bilateral Dual Transversus Abdominis Plane Block
  75. A drug rape case involving triazolam detected in hair and urine
  76. In Vivo Imaging of Cerebral Serotonin Transporter and Serotonin2A Receptor Binding in 3,4-Methylenedioxymethamphetamine (MDMA or “Ecstasy”) and Hallucinogen Users
  77. Postmortem Femoral Blood Concentrations of Amlodipine
  78. Simultaneous Determination of γ-Hydroxybutyrate (GHB) and its Analogues (GBL, 1.4-BD, GVL) in Whole Blood and Urine by Liquid Chromatography Coupled to Tandem Mass Spectrometry
  79. Postmortem Blood Concentrations of R‐ and S‐Enantiomers of Methadone and EDDP in Drug Users: Influence of Co‐Medication and P‐glycoprotein Genotype
  80. Simultaneous screening and quantification of 52 common pharmaceuticals and drugs of abuse in hair using UPLC–TOF-MS
  81. Determination of Olanzapine in Whole Blood Using Simple Protein Precipitation and Liquid Chromatography-Tandem Mass Spectrometry
  82. Determination of amphetamine, methamphetamine, MDA and MDMA in human hair by GC‐EI‐MS after derivatization with perfluorooctanoyl chloride
  83. Chiral Analysis of Methadone and its Main Metabolite EDDP in Postmortem Blood by Liquid Chromatography-Mass Spectrometry
  84. Dominance of pre-analytical over analytical variation for measurement of methadone and its main metabolite in postmortem femoral blood
  85. Quantitative analysis of cocaine and its metabolites in whole blood and urine by high-performance liquid chromatography coupled with tandem mass spectrometry
  86. Chiral separation and quantification of R/S-amphetamine, R/S-methamphetamine, R/S-MDA, R/S-MDMA, and R/S-MDEA in whole blood by GC-EI-MS
  87. Liquid chromatography–tandem mass spectrometry determination of LSD, ISO-LSD, and the main metabolite 2-oxo-3-hydroxy-LSD in forensic samples and application in a forensic case
  88. Drugs in injured drivers in Denmark
  89. AMP kinase expression and activity in human skeletal muscle: effects of immobilization, retraining, and creatine supplementation
  90. Liquid chromatography?tandem mass spectrometry determination of loperamide and its main metabolite desmethylloperamide in biological specimens and application to forensic cases
  91. A fatal overdose of the ergot derivative cabergoline
  92. A fatal case of amlodipine poisoning
  93. Fatal overdose of the herbicide bentazone
  94. Three Fatal Cases of PMA and PMMA Poisoning in Denmark
  95. Metabolic pathways of quinoline, indole and their methylated analogs by Desulfobacterium indolicum (DSM 3383)
  96. Transformation of indole and quinoline by Desulfobacterium indolicum (DSM 3383)
  97. DEGRADATION PATHWAY OF QUINOLINES IN A BIOFILM SYSTEM UNDER DENITRIFYING CONDITIONS
  98. Method development for trace analysis of heteroaromatic compounds in contaminated groundwater
  99. Comparison of high-performance liquid chromatographic methods for the determination of 1,2-dibromo-2,4-dicyanobutane in cosmetic products